These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 25060672)

  • 1. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
    Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer.
    Getzler I; Bahouth Z; Nativ O; Rubinstein J; Halachmi S
    BMC Urol; 2018 Oct; 18(1):90. PubMed ID: 30348146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
    Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
    Vartolomei MD; Ferro M; Cantiello F; Lucarelli G; Di Stasi S; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdona S; Verze P; La Rocca R; Borghesi M; Schiavina R; Brunocilla E; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Battaglia M; Serretta V; Russo GI; Morgia G; Terracciano D; Musi G; de Cobelli O; Mirone V; Shariat SF
    Clin Genitourin Cancer; 2018 Dec; 16(6):445-452. PubMed ID: 30077463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
    Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
    Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
    Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
    Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the neutrophil-to-lymphocyte ratio be used to predict recurrence and progression of non-muscle-invasive bladder cancer?
    Albayrak S; Zengin K; Tanik S; Atar M; Unal SH; Imamoglu MA; Gurdal M
    Kaohsiung J Med Sci; 2016 Jun; 32(6):327-33. PubMed ID: 27377847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.
    D'Andrea D; Moschini M; Gust K; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
    Clin Genitourin Cancer; 2017 Oct; 15(5):e755-e764. PubMed ID: 28420564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
    Ogihara K; Kikuchi E; Yuge K; Yanai Y; Matsumoto K; Miyajima A; Asakura H; Oya M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1039-1047. PubMed ID: 27660257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
    Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi PF
    Int Braz J Urol; 2019; 45(2):315-324. PubMed ID: 30785697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
    Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M
    Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of preoperative neutrophil to lymphocyte ratio in prediction of recurrence, progression, and BCG failure in non-muscle invasive bladder cancer: a retrospective study.
    Ziani I; Ibrahimi A; Zaoui Y; El Sayegh H; Abouqal R; Nouini Y; Bouziane A
    Pan Afr Med J; 2023; 44():145. PubMed ID: 37396698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
    Lee SM; Russell A; Hellawell G
    Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.